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Background: The present study described the phytochemical profile of Lavandula stoechas essential oils, collected
in the area of Ain-Draham (North-West of Tunisia), as well as their protective effects against alloxan-induced
diabetes and oxidative stress in rat.
Methods: Essential oils samples were obtained from the aerial parts of the plant by hydrodistillation and analyzed
by GC–MS. Rats were divided into four groups: Healthy Control (HC); Diabetic Control (DC); Healthy + Essential Oils
(H + EO) and Diabetic + Essential Oils (D + EO).
Antidiabetic and antioxidant activities were evaluated after subacute intraperitoneally injection of Lavandula
stoechas essential oils (50 mg/kg b.w., i.p.) to rats during 15 days.
Results: The principal compounds detected are: D-Fenchone (29.28%), α-pinene (23.18%), Camphor (15.97%),
Camphene (7.83%), Eucapur (3.29%), Limonene, (2.71%) Linalool, (2.01%) Endobornyl Acetate (1.03%). The essential
oils also contained smaller percentages of Tricyclene, Cymene, Delta-Cadinene, Selina-3,7(11)-diene. Furthermore,
we found that Lavandula stoechas essential oils significantly protected against the increase of blood glucose as well
as the decrease of antioxidant enzyme activities induced by aloxan treatment. Subacute essential oils treatment
induced a decrease of lipoperoxidation as well as an increase of antioxidant enzyme activities.
Conclusions: These findings suggested that lavandula stoechas essential oils protected against diabetes and
oxidative stress induced by alloxan treatment. These effects are in partly due to its potent antioxidant properties.
Keywords: Lavandula Stoechas, Alloxan, Rat, Essential oils, Antioxidant, AntidiabeticIntroduction
The Mediterranean diet has been credited with many
beneficial effects in the prevention and treatment of car-
diovascular diseases [1], including improvement of lipid
profiles, reduction in blood pressure, insulin resistance,
blood glucose concentration and inflammatory biomarkers
[2]. Oxidative stress is believed to be a primary factor in
various diseases as well as in the normal process of aging
[3,4]. Free radicals and reactive oxygen species (ROS)
are well known as inducers of cellular and tissue pathogen-
esis leading to several human diseases such as cancer, in-
flammatory disorders, atherosclerosis and cardiovascular* Correspondence: slimen.selmi@gmail.com
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reproduction in any medium, provided the ordiseases [5,6]. Cardiovascular diseases are the most
common cause of death in the industrialized countries
[7]. Many epidemiological and experimental studies
have shown that phenolic compounds intake is in-
versely correlated with atherosclerosis development
and related cardiovascular events [8-10]. The beneficial
effect of polyphenols is associated with a multitude of
biological activities, including antioxidant and free radical-
scavenging properties, anti-platelet aggregation and inhib-
ition of vascular smooth muscle cell proliferation. These
observations might explain their cardiovascular protective
properties [11]. On the other hand, it is now established
that hyperlipidaemia represents a major risk factor for the
premature development of atherosclerosis and its cardio-
vascular complications [12]. A logical strategy to prevent
against atherosclerosis and reduce the incidence oftd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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emia and oxidative stress by diet and/or drug intervention.
Lavender (Lavandula stoechas L.) is a medicinal plant
largely used in the Tunisian traditional medicine. In fact,
this plant is known to protect against headaches, depression
and diabetes [13,14]. Lavandula stoechas essential oils are
rich in monoterpenes and employed for its antimicrobial,
antifungal and carminative properties as well as its cosmetic
purposes [14-16]. Its leaves and stems are used to prepare
decoctions against rheumatism, chill and digestive system
diseases [17]. Furthermore, Lavender essential oils are ad-
vocated for their use as an antibacterial agent in both early
and modern aromatherapy texts [18,19].
Lavender has been extensively phytochemically stud-
ied, with limited work on pharmacological aspects and is
used by traditional healers for various diseases of the
central nervous system, like epilepsy and migraine [20].
It is also used in folk medicine, as an antispasmodic in
colic pain and has analgesic, tranquillizer and antiseptic
effects [20-23]. Lavender extracts have also positive ef-
fects on wound, urinal infections, cardiac diseases and
eczema [22]. This species has been also shown to reduce
blood sugar levels [13].
In the present study, we studied the protective effect
of the lavandula stoechas essential oils against diabetes
and oxidative stress induced by alloxan treatment in rat.




Alloxan monohydrate, 5,5-dithio bis(2-nitrobenzoic acid)
(DTNB), trichloroacetic acid (TCA), KOH, ethanol, ether,
bovine serum albumin, orthophosphoric acid 85%, and
NaCl were obtained from Sigma-Aldrich Co. (Germany).
Plant collection
Lavandula stoechas (L. stoechas) aerial parts were col-
lected in March, 2010 from the area of Ain-Draham
(North-West of Tunisia) and identified by the labora-
tory of taxonomy in the Faculty of Sciences of Tunis
(FST)-Tunisia. The Voucher specimens (No. L101) have
been deposited with the herbarium of the Higher Insti-
tute of Biotechnology of Béja and also in Department of
Biological Sciences, Faculty of Science, Tunisia.Plant extracts preparation
The dried aerial parts were submitted to hydrodistillation
for 3 hours using Clevenger type apparatus, according to
the European Pharmacopoeia (1996). Briefly, the plant was
immersed in water and heated to boiling, after which the
essential oils were evaporated together with water vapour
and finally collected in a condenser. The distillate wasisolated and dried over anhydrous sodium sulfate. The oils
farctions were stored at 4°C until analysis by GC–MS.
Free radical-scavenging activity on DPPH
The antioxidant capacity of the Lavender essential oils
was performed using 2,2-diphenyl-1-picrylhydrazyl (DPPH)
radical-scavenging activity as previously described by
Grzegorczyk et al. [24]. Briefly, Various concentrations
of the essential oils (20, 50, 100, 150, and 200 μg/ml) were
added to 1 ml of 0.1 mM methanol solution of DPPH and
incubated at 27°C during 30 min. The absorbance of the
sample was measured at 517 nm. DPPH radical-scavenging
activity (RSA), expressed as percentage was calculated using
the following formula:




Ascorbic acid was used as a reference molecule in the
same concentration as the test extract.
All the analyses were done in triplicate. The efficacy
concentration 50 (EC50) value was defined as the con-
centration (in μg/ml) of the compound required to scav-
enge 50% of the DPPH radical.
Gas chromatography–mass spectrometry (GC-MS)
The essential oils of L. Stoechas were subjected to GC-MS
analysis using Trace GC ULTRA/Polaris Q (GC-MS,
Thermo Electron). The column was a VB-5 (5% phenyl/
95% dimethylpolysiloxane) with film thickness of 0.25 μm,
a length of 30 m and an internal diameter of 0.25 μm he-
lium was used as carrier gas. The GC oven temperature
was kept at 50°C for 5 min and programmed to 250°C for
3 min at rate of 4°C/min and programmed to 300°C at rate
of 25°C/min. The injector temperature was set at 250°C.
Split flow was adjusted at 50 mL/min. MS were taken at
70 eV. Mass range was from uma 20 to 350. A library
search was carried out using the “Wiley GC/MS Library”,
Nist and Pmw. The sample was dissolved in Hexane.
Animals and treatment
Adult male Wistar rats (weighing 220–230 g, 15 weeks old
and housed five per cage) were purchased from SIPHAT
(Tunis, Tunisia) and used in accordance with the local
ethic committee of Tunis University for use and care of
animals in conformity with the NIH recommendations.
The animals were housed in standard cages (40× 28 ×16
cm) under controlled conditions: 12:12-h light–dark, 20–
22°C, food and water are ad libitum. After diabetes induc-
tion, rats were divided into 4 groups of 12 animals each:
Group I: non-diabetic rat (control) treated with NaCl
(0.9%, i.p.) during 15 days.
Group II: diabetic rat (alloxan, 220 mg/kg b.w.) treated
with NaCl (0.9%) during 15 days.
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(50 mg/kg b.w., i.p.) during 15 consecutive days.
Group IV: diabetic rat (alloxan, 220 mg/kg b.w. i.p.)
treated with essential oils (50 mg/kg b.w., i.p.) during 15
consecutive days.
Twenty hours after the last injection, animals were sacri-
ficed, blood was collected in heparinized tubes. After cen-
trifugation at 3 000 g for 15 min, plasma was processed
for biochemical parameter determinations. The liver and
the kidney were rapidly excised and homogenized in phos-
phate buffer saline. After centrifugation at 10 000 g for
10 min at 4°C, supernatants were used for biochemical de-
termination of protein, -SH groups, MDA and antioxidant
enzyme activities.
Induction of experimental diabetes
Experimental diabetes was induced in 12 h fasted rats by
single i.p. injection of alloxan (220 mg/kg body weight)
[25] dissolved in citrate buffer (100 mM, pH 4.5). To pre-
vent fatal hypoglycaemia as a result of massive pancreatic
insulin release, the rats were supplied with 10% glucose so-
lution after 6 hours of alloxan administration for the next
24 hours. After seven days, rats with glycemia ≥14 mM
were selected for the experiment.
Lipid peroxidation
Lipid peroxidation was detected by the determination of
MDA production determined by the method of Begue and
Aust [26]. Briefly, homogenates of liver and kidney were
centrifuged at 1000 g for 10 min at 4°C to sediment cell
debris and mitochondrial samples. Supernatants were sus-
pended in PBS, pH = 7.4, mixed with BHT-TCA (Trichltor-
acetic acid, Buthylhydroxytoluen) solution (1‰ w/v BHT
dissolved in 20% TCA), centrifuged at 1000 g for 35 min
and finally mixed with 0.5 N HCl and 120 mM TBA (Thio-
barbituric acid) in 26 mM Tris and heated in water bath at
80°C for 10 min. After cooling, the absorbance of the
resulting chromophore was measured at 532 nm. MDA
levels were determined by using an extinction coefficient
for MDA-TBA complex of 1.56 105 M-1 cm-1.
Thiol groups measurement
Total concentration of thiol groups (−SH) was per-
formed according to Ellman’s method [27]. Briefly, ali-
quots from liver tissue was mixed with 100 μl of 10%
SDS and 800 μl of 10 mM phosphate buffer (pH 8) and
the absorbance was measured at 412 nm (A0). Then,
100 μl of DTNB were added and incubated at 37°C dur-
ing 60 min. After incubation the absorbance of the sam-
ple was measured at 412 nm (A1). The thiol groups
concentration was calculated from A1-A0 subtraction
using a molar extinction coefficient of 13.6 × 103 M-1 ×
cm-1. Results were expressed as nmol of thiol groups
per mg of protein.Antioxidant enzyme activities assays
The activity of superoxide dismutase (SOD) was assessed
by the spectrophotometric method of Misra and Fridovich
[28]. Mn-SOD activity was measured in the presence of
2.0 mM sodium cyanide, an inhibitor of Cu, Zn-SOD [29].
Catalase (CAT) activity was measured by the method of
Aebi [30].
Protein determination
Protein concentration was determined according to
Bradford method [31]. Serum albumin was used as standard.
Functional and metabolic parameters
Glycaemia assays
Glucose was measured by the glucose oxidase and perox-
idase using quinoneimine as a chromogen. The amount of
plasma glucose is related to amount of quinoneimine,
which is measured spectrophotometrically at 505 nm [32].
Assessment of liver function
Plasma aspartate aminotransferase (AST), alanine ami-
notransferase (ALT), phosphatase alcaline (PAL), lactate
dehydrogenase (LDH) were measured using commer-
cially available diagnostic kits (Biomaghreb, Ariana, TN).
Assessment of renal function
Plasma urea, creatinine, uric acid and albumin analyses
were performed using commercially available diagnostic
kits (Biomaghreb, Ariana, TN).
Metabolic parameters
Plasma total cholesterol (TC), low-density lipoprotein-
cholesterol (LDL), high-density lipoprotein-cholesterol
(HDL) and triglyceride (TG) concentrations were mea-
sured using commercially available diagnostic kits supplied
by Randox laboratories (Ardmore, Northern Ireland, UK).
Statistical analyses
Data were analyzed by unpaired Student t-test and are
expressed as mean ± standard deviation. Data are represen-
tative of 12 independent experiments. All statistical tests
were two-tailed, and a p value of 0.05 or less was consid-
ered significant.Results
Chemical composition of the lavender essential oils
The results obtained by GC–MS analyses of the L. stoe-
chas essential oils (extraction yield = 0.05%) are presented
in Table 1. Twenty two compounds were identified. The
principal compounds detected are: D-Fenchone (29.28%),
α-pinene (23.18%), Camphor (15.97%), Camphene (7.83%),
Eucapur (3.29%), and Limonene, (2.71%) Linalool, (2.01%)
Endobornyl Acetate (1.03%). The essential oils also
Table 1 Phytochemical compositions of L. Stoechas
essential oils are presented in Table 1
No Components IR Compositions (%)
1 Tricyclene 6.137 0.51
2 α-pinene 6.720 23.18
3 Camphene 7.310 7.83
4 β-Phellandrene 8.500 0.10
5 β -Pinene 8.626 0.12
6 Delta 3-Carene 10.554 0.11
7 Cymene 11.504 0.72
8 Limonene 11.807 2.71
9 Eucapur 11.893 3.29
10 D-Fenchone 15.835 29.28
11 Linalool 16.785 2.01
12 Camphor 19.526 15.97
13 Myrtenol 23.228 0.26
14 Endobornyl acetate 29.122 1.03
15 Aromad endrene 33.991 0.28
16 α -Copaene 34.809 0.28
17 Caryophyllene 37.436 0.26
18 β -Selinene 41.533 0.26
19 Delta-Cadinene 43.953 0.67
20 α -Elemene 44.434 0.12
21 Selina-3,7(11)-diene 44.817 0.85
22 Delta-gurjunene 47.730 0.20






























L. stoechas essential oils
Figure 1 Free radical-scavenging activity of Lavandula
stoechas essential oils and ascorbic acid on 2,2-diphenyl-1-
picrylhydrazyl (DPPH).
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Delta-Cadinene, Selina-3,7(11)-diene.Antioxidant capacity of the lavender essential oils
Concerning the antioxidant capacity, we showed in Figure 1
that the radical-scavenging activity (RSA) of L. stoechas
essential oils and ascorbic acid against DPPH radical in-
creased significantly in a dose-dependant manner. How-
ever, L. stoechas essential oils showed an important RSA
(EC50 = 221.43 μg/mL) but lesser than ascorbic acid
(EC50 = 87.57 μg/mL) used as reference molecule.Body and relative organs weights
The weight gain has significantly decreased in alloxan-
induced diabetic rats compared to healthy non diabetic
animals. Subacute Lavender essential oils administration
prevented this decline and protected also against alloxan-
induced increase hepatic and renal relative weights
(Table 2).Blood glucose level
Significant increase in blood glucose level was observed in
alloxan-induced diabetic rats compared to healthy non-
diabetic animals (Table 3). Lavender essential oils treat-
ment corrected significantly this decrease, while essential
oils alone had no significant effect.Effect of lavender essential oils on hepatic and renal lipid
peroxidation and thiol groups content
Alloxan-induced diabetes significantly increased liver
and kidney MDA level as index of lipid peroxidation
and decreased thiol groups content compared to
healthy non-diabetic group (Figure 2A,B,C and D).
Treatment with lavender essential oils (50 mg/kg b.w.,
i.p.) protected against the lipoperoxidation as well as
the decrease of (−SH) groups level induced by alloxan
treatment. Lavender essential oils alone had no effect
on lipid peroxidation.Effect of lavender essential oils on liver and kidney
antioxidant enzyme activities
We further looked at the effects of alloxan and Lavender
essential oils treatment on hepatic and renal antioxidant
enzymes activities. Results presented in the Figure 3A,B,C
and D, showed that alloxan administration significantly de-
creased hepatic and renal antioxidant enzyme activities as
CAT, total SOD, cu/zn-SOD and Mn-SOD. Lavender es-
sential oils treatment significantly reversed alloxan-induced
antioxidant enzymes depletion.
Table 2 Subacute effect of Lavandula stoechas essential oils on acute aloxan-induced changes body weight as well as
liver and kidney relative weights
Healthy control Diabetic control Healthy + essential oils Diabetic + essential oils
Initial body weight (g) 227 ± 2.8 228 ± 2.3 230 ± 2.6 227 ± 2.9
Final body weight (g) 241 ± 2.7 227 ± 2.4a 244 ± 2.4b 231 ± 3.1b
Liver relative weight (mg/g b.w.) 33.42 ± 3.91 62. 13 ± 2.81a 36.83 ± 3.45b 39.51 ± 2.27b
Kidney relative weight (mg/g b.w.) 8.7 ± 0.2 11.13 ± 0.71a 8.36 ± 0.94b 7.89 ± 0.49b
Animals were treated during 15 days with Lavandula stoechas essential oils (50 mg/kg b.w., i.p.) or vehicle (NaCl 0.9%) seven days after diabetic induction with
alloxan at 220 mg/kg b.w.. Assays were carried out in triplicate.
ap < 0.05 compared to “Healthy Control” group and bp < 0.05 compared to “Diabetic Control” group.
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kidney functions
The exposure of rats to alloxan led to liver dysfunctions
as indicated by the of AST, ALT, ALP and LDH activities
(Table 3). Concerning kidney function, we showed that
alloxan exposure induced an increase of plasma creati-
nin and urea levels as well as a decrease of albumin and
acid uric contents (Tables 2 and 3). Treatment with L.
stoechas essential oils (50 mg/kg b.w., i.p.) significantly
protected against hepatic and renal dysfunctions induced
by alloxan treatment.
Effect of lavender essential oils on lipid metabolic
parameters
Table 4 showed that alloxan exposure of rat induced
considerable metabolic disorders. Indeed, alloxan treat-
ment of rats significantly increased the TG, TC and LDL
plasma contents and decreased the HDL level. Import-
antly, we showed that L. stoechas essential oils supple-
mentation significantly protected against the disturbance
of lipid metabolic parameters induced by alloxan.
Discussion
It was noteworthy that the composition of L. stoechas es-
sential oils in North Africa was in partial agreement with
the previous report [33]. Thus, 8-cineole constituted the
major constituent of Lavandula essential oils in agreementTable 3 Subacute effect of Lavandula stoechas essential oils o
kidney functions
Glucose ALT AST ALP
(mM) (UI/L) (UI/L) (UI/L)
Healthy control 6.65 ± 0.66 23 ± 1.59 39 ± 2.82 129 ± 7.1
Diabetic
control
15.29 ± 1.1a 63 ± 1.38a 68 ± 2.13a 179 ± 6.5a
Healthy +
essential oils
5.17 ± 0.6b 21 ± 1.75b 37 ± 3.63b 148 ± 6.8b
Diabetic +
essential oils
7.81 ± 0.71b 32 ± 1.37b 43 ± 2.51b 155 ± 9.6
Animals were treated during 15 days with Lavandula stoechas essential oils (50 mg/
alloxan at 220 mg/kg b.w.. Assays were carried out in triplicate.
ap < 0.05 compared to “Healthy Control” group and bp < 0.05 compared to “Diabeticwith previous report [33]. In contrast, other compounds
as p-cymen-8-ol, pinocarvone and α-terpineol and α -
terpinen-7-al and fenchone, were not detected in our
sample, but were found in other report [34]. Sabinene,
which was present at low concentration (1.4%) in the
previous report [34], represented one of the major con-
stituents in our sample (13.89%). These changes in the
essential oils composition are mainly related to the cli-
matic and geographic conditions as well as genetic dif-
ferences [33]. However, several investigations on the
essential oils of various Lavandula species [33,35-37]
showed that 1, 8- cineole, linalool, linalyl acetate, fench-
one and β-phellandrene are the characteristic com-
pounds of these plants.
On the other hand, using the DPPH radical-scavenging
assay we showed that L. stoechas essential oils presented a
higher scavenging capacity which may be related to the
presence of phenolic compounds in accord with previ-
ous reports [33-37]. However, this antioxidant capacity
remained lower than that of ascorbic acid.
Alloxan administration produced diabetes status by
destruction of pancreatic β-cells [38] with changes in
metabolic variables as well as kidney and liver func-
tions. We firstly found that alloxan injection decreased
body weight gain and increased kidney and liver relative
weights. We also showed that alloxan administration in-
creased glycaemia, cholesterol, triglycerides, urea, uricn acute aloxan-induced changes in liver and
LDH Albumin Urea Uric acid Creatinin
(U/L) (g/dl) (mmol/L) (mmol/L) (μmol/L)
938 ± 16 4.72 ± 0.93 7.64 ± 0.38 0.28 ± 0.01 114 ± 6.7
1246 ± 24a 3.15 ± 0.96a 10.8 ± 0.40a 0.13 ± 0.02a 163 ± 5.9a
916 ± 13b 5.34 ± 0.30b 7.14 ± 0.35b 0.28 ± 0.01b 126 ± 6.3b
1095 ± 38b 4.13 ± 0.35b 7.21 ± 0.89 0.29 ± 0.01b 119 ± 8.4b


























































































































Figure 2 Subacute effect of Lavandula stoechas essential oils on acute aloxan-induced changes in liver and kidney MDA (A and B) and (−SH)
groups (C and D) levels. Animals were treated during 15 days with Lavandula stoechas essential oils (50 mg/kg b.w., i.p.) or vehicle (NaCl 0.9%) sevan days
after diabetic induction with alloxan at 220 mg/kg b.w.. Assays were carried out in triplicate. HC: Healthy Control; DC: Diabetic Control; H+ EO: Healthy +
Essential Oils; D+ EO: Diabetic + Essential Oils. “a”: p< 0.05 compared to “Healthy Control” group and “b”: p< 0.05 compared to “Diabetic Control” group.
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alloxan-induced diabetes mellitus, the rise in blood glu-
cose is also accompanied by an increase in plasma chol-
esterol, triglycerides and urea [39,40].
The diabetogenic effects of alloxan are partly attrib-
uted to the specific cytotoxic action mediated by reactive
oxygen species generation leading to the damage of large
number of β-cells accompanied by a decrease in en-
dogenous insulin release. However, alloxan-administered
rats became hyperglycaemic in a short period of time,
followed by a hepatic glucose overproduction [41]. More
importantly, we have shown that L. stoechas essential oils
decreased blood glucose in alloxan-diabetic rats. L. stoe-
chas oils may exert their antihyperglycaemic effect by po-
tentiating plasma insulin action, secretion or its release
from bound form [42]. In diabetic status, lipoprotein lipase
is not activated due to insulin deficiency resulting in
hypertriglyceridemia and hypertriglyceridemia. This is in
agreement with the fact that the glycemia level is the
major determinant of total and very low-density lipopro-
tein cholesterol concentrations [43]. Our data indicated
that alloxan-induced diabetic rats presented high levels of
plasma urea, uric acid and creatinine, which are consid-
ered as significant markers of renal function [44,45].
Treatment with L. stoechas essential oils reversed all these
parameters to near control levels. The increase of plasmaAST and ALT activities indicated that diabetes may induce
hepatic dysfunction as supported by previously findings
showing a necrotic liver [46]. Therefore, the increase of
transaminase activities in plasma may be mainly due to
the leakage of these enzymes from the liver [47]. On the
other hand, treatment of the alloxan-diabetic rats with
L. stoechas essential oils restored the transaminase activ-
ities. These results are in line with those obtained by
Ohaeri [48] and illustrate the hepatoprotective effects of
lavender against alloxan-induced toxicity.
More importantly, L. stoechas supplementation, pro-
tected against alloxan-induced decrease of plasma uric
acid concentration as one of the major endogenous
water-soluble antioxidants [49], as well as tissue malon-
dialdehyde increase, as marker of lipid peroxidation
[50]. We also showed that alloxan administration de-
creased antioxidant enzymes activities such as SOD and
CAT. However, these enzymes are known to be inhib-
ited in diabetic model as a result of non-enzymatic gly-
cosylation and oxidation [51]. These results corroborate
previous reports [51,52] indicating the interaction be-
tween diabetes and ROS generation. Subacute treatment
of alloxn-treted rats with L. stoechas essential oils in-
creased the activities of these enzymes, which might be
due to decreased oxidative stress. Previous studies have




























































































































































Figure 3 Subacute effect of Lavandula stoechas essential oils on acute aloxan-induced changes in liver and kidney CAT (A and B), Total SOD,
Cu/Zn-SOD, Mn-SOD and Fe-SOD (C and D). Animals were treated during 15 days with Lavandula stoechas essential oils (50 mg/kg b.w., i.p.) or vehicle
(NaCl 0.9%) sevan days after diabetic induction with alloxan at 220 mg/kg b.w.. Assays were carried out in triplicate. HC: Healthy Control; DC: Diabetic
Control; H+ EO: Healthy + Essential Oils; D+ EO: Diabetic + Essential Oils. “a”: p< 0.05 compared to “Healthy Control” group and “b”: p< 0.05 compared to
“Diabetic Control” group.
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cules are the primal source of antioxidant ability of
this plant, by scavenging free radicals as hydroxyl
radical (OH.) which is the major cause of lipid perox-
idation [54]. However, diabetic status is accompanied
by high oxidative stress due to persistent and chronic
hyperglycaemia leading to the depletion of antioxi-
dant defense system and free radicals generation [55].
Hydroxyl radical (OH.) reacts with all biological sub-
stances and the most susceptible ones are polyunsat-
urated fatty acids leading to lipid peroxidation [56].Table 4 Subacute effect of Lavandula stoechas essential oils o
metabolic parameters
TG (mg/ml) TC (mg/ml)
Healthy control 0.66 ± 0.02 0.72 ± 0.02
Diabetic control 1.28 ± 0.07a 0.87 ± 0.04a
Healthy + essential oils 0.68 ± 0.16b 0.68 ± 0.03b
Diabetic + essential oils 0.86 ± 0.12b 0.74 ± 0.04b
Animals were treated during 15 days with Lavandula stoechas essential oils (50 mg/
alloxan at 220 mg/kg b.w.. Assays were carried out in triplicate.
ap < 0.05 compared to “Healthy Control” group and bp < 0.05 compared to “DiabeticIndeed, increased lipoperoxidation impairs mem-
brane function by decreasing membrane fluidity and
changing the activity of membrane-bound enzymes
and receptors [57].
In conclusion, our data clearly demonstrated the pro-
tective effects of the lavandula stoechas essential oils
against diabetes and oxidative stress induced by al-
loxan treatment in rat. Lavender essential oils de-
creased kidney and hepatic injuries mainly through
their antioxidant properties and played a major role as
hepato- and nephroprotector products.n acute aloxan-induced changes in lipid
HDL (mg/ml) LDL (mg/ml) TG/HDL TC/HDL
0.19 ± 0.02 0.21 ± 0.03 3.47 3.78
0.13 ± 0.02a 0.34 ± 0.02a 9.84a 6.29a
0.14 ± 0.01b 0.24 ± 0.02b 4.85b 4.85b
0.16 ± 0.02b 0.27 ± 0.03b 5.37b 4.62b
kg b.w., i.p.) or vehicle (NaCl 0.9%) seven days after diabetic induction with
Control” group.
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